This Solicitation opportunity from Department Of Defense was posted on May 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
POVIDONE-IODINE TOP
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Povidone-Iodine Topical Solution, USP, in a 10 percent concentration, packaged in 1/2 fl oz (15 mL) bottles, with a unit of issue defined as PG (50 bottles per unit). The item is regulated by the FDA and is classified as a critical application medical product with a non-extendable shelf life of 36 months, requiring that at least 31 months of shelf life remain upon delivery to the first government activity. Packaging and labeling must comply with Medical Marking Standard No. 1 dated February 4, 2013, which supersedes MIL-STD-129 for medical items, and must include proper identification as specified in the DLA Master List of Technical and Quality Requirements. Each unit must be sealed and protected to prevent damage, and all shipping containers must ensure safe, cost-effective delivery by common carrier to the destination address in San Antonio, Texas. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged per ASTM D3951, though DLA requirements take precedence over any conflicting commercial standards. Palletization must adhere to RP001 DLA Packaging Requirements for Procurement, and shipment must occur via traceable freight methods, excluding parcel post. Delivery is required within 20 days after award, with FOB destination terms placing transportation risk and responsibility on the contractor until receipt at the specified location. Inspection and acceptance occur at the destination, and the contractor must ensure full compliance with all marking, labeling, and documentation standards. Pricing details are not specified in the solicitation, and no contract value is formally stated, though prior pricing history is referenced for context. The solicitation number is SPE2DP-26-T-3414, with a response deadline of May 26, 2026, and it falls under simplified acquisition procedures. The contracting office is part of the Department of Defense’s Medical Supply Chain Pharm FSA, and offers must be submitted electronically through the DLA Internet Bid Board System. The contract includes numerous standardized FAR and DFARS clauses addressing equal opportunity, trafficking prevention, cybersecurity, export controls, hazardous materials handling, and subcontracting, with several deviations applied to clauses related to safeguarding information systems and subcontracting for commercial items. Offerors are required to provide their Unique Entity Identifier and comply with all socioeconomic representations, and while the contract type is not explicitly stated, it is
General Info
Agency
NAICS
Place of Performance
PR: 7016784095 PRLI: 0001 CONT’D, SAN ANTONIO, TX, 78226, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
POVIDONE-IODINE TOPICAL SOLUTION, USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
10 PCT, 1/2 FL OZ (15 ML), 50'S
.
U/I "PG" (50 BOTTLES)
.
SHELF LIFE IS 36 MONTHS; 31 MONTHS OF SHELF LIFE SHALL REMAIN AT TIME OF
DELIVERY TO THE FIRST GOV'T ACTIVITY.
.
LABELING AND MARKINGS SHALL BE IN ACCORDANCE WITH THE MEDICAL MARKING
STANDARDS 1A DATED 2/4/2013
.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . 1 PG = 50 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
SPE2DP-26-T-3414
SECTION B
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
CRITICAL APPLICATION ITEM
PURDUE PHARMA LP 3LEA3 P/N NDC67618-0150-05
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016784095 0001 PG 1.000
NSN/MATERIAL:6505009143593
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
FM9133
FM9133 AFMEDCOM A4 10W A410W
BLDG 1534 CP 2103383375
601 DAVY CROCKETT RD
SPE2DP-26-T-3414
SECTION B
PR: 7016784095 PRLI: 0001 CONT’D
SAN ANTONIO TX 78226
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
FM9133
FM9133 AFMEDCOM A4 10W A410W
BLDG 1534 CP 2103383375
601 DAVY CROCKETT RD
SAN ANTONIO TX 78226
US
M/F: (TCN) FM913361330058
RDD:
PROJ: TP 2
SUPP ADD: YNONE SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A0A DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3414 NSN/Part Number: 6505-00-914-3593 Quantity: 1 PG Purchase Request: 7016784095QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS